Enoxacin therapy for severe pleuro-pulmonary infections.

No Thumbnail Available
Date
1991-10-01
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Enoxacin, a new 6-fluoroquinolone known to be active in vitro against most common pulmonary pathogens, was evaluated in comparison with ceftazidime, a third generation cephalosporin proven to be effective in the treatment of gram negative pneumonias. Clinical and microbiologic responses to therapy were satisfactory and comparable in both antibiotic groups. Enoxacin could be an effective alternative choice in the treatment of lower respiratory tract infections caused by gram negative organisms.
Description
Keywords
Citation
Thadepalli H, Mathai D, Bansal MB, Chuah SK. Enoxacin therapy for severe pleuro-pulmonary infections. Journal of the Association of Physicians of India. 1991 Oct; 39(10): 747-9
URI
https://imsear.searo.who.int/handle/123456789/92529
Collections
Journal of the Association of Physicians of India